Skip to content
← Full study record

NCT04442126 · FLOW

Participant flow

A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors · Source last updated 2025-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Flat dose level; 0.15mg (Dose Level 1)
    id
    FG000
    title
    Part A Dose Level 1 NM21-1480-Q2W 0.15mg
  2. description
    Flat dose level; 1.5mg (Dose Level 2)
    id
    FG001
    title
    Part A Dose Level 2 NM21-1480-Q2W 1.5mg
  3. description
    Flat dose level; 8mg (Dose Level 3)
    id
    FG002
    title
    Part A Dose Level 3 NM21-1480-Q2W 8mg
  4. description
    Flat dose level; 24mg (Dose Level 4)
    id
    FG003
    title
    Part A Dose Level 4 NM21-1480-Q2W 24mg
  5. description
    Flat dose level; 80mg (Dose Level 5)
    id
    FG004
    title
    Part A Dose Level 5 NM21-1480-Q2W 80mg
  6. description
    Flat dose level; 240mg (Dose Level 6)
    id
    FG005
    title
    Part A Dose Level 6 NM21-1480-Q2W 240mg
  7. description
    Flat dose level; mg800 (Dose Level 7)
    id
    FG006
    title
    Part A Dose Level 7 NM21-1480-Q2W 800mg
  8. description
    This part of the study consisted of a 1400mg flat dose across one cohort.
    id
    FG007
    title
    Part A2 NM21-1480-Q2W
  9. description
    This part of the study consisted of a 800mg flat dose across three cohorts.
    id
    FG008
    title
    Part B NM21-1480-Q2W
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        2
      5. group Id
        FG004
        num Subjects
        1
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        1
      8. group Id
        FG007
        num Subjects
        1
      9. group Id
        FG008
        num Subjects
        3
      type
      Withdrawal by Subject
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        1
      5. group Id
        FG004
        num Subjects
        2
      6. group Id
        FG005
        num Subjects
        2
      7. group Id
        FG006
        num Subjects
        4
      8. group Id
        FG007
        num Subjects
        1
      9. group Id
        FG008
        num Subjects
        5
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        1
      7. group Id
        FG006
        num Subjects
        4
      8. group Id
        FG007
        num Subjects
        2
      9. group Id
        FG008
        num Subjects
        10
      type
      Study Terminated by Sponsor
    4. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        1
      9. group Id
        FG008
        num Subjects
        2
      type
      Lost to Follow-up
    5. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        3
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      9. group Id
        FG008
        num Subjects
        0
      type
      Progressive Disease
    6. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      9. group Id
        FG008
        num Subjects
        1
      type
      Other
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        6
      6. group Id
        FG005
        num Subjects
        3
      7. group Id
        FG006
        num Subjects
        9
      8. group Id
        FG007
        num Subjects
        5
      9. group Id
        FG008
        num Subjects
        21
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      9. group Id
        FG008
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        6
      6. group Id
        FG005
        num Subjects
        3
      7. group Id
        FG006
        num Subjects
        9
      8. group Id
        FG007
        num Subjects
        5
      9. group Id
        FG008
        num Subjects
        21
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Flat dose level; 0.15mg (Dose Level 1)
    id
    FG000
    title
    Part A Dose Level 1 NM21-1480-Q2W 0.15mg
  2. description
    Flat dose level; 1.5mg (Dose Level 2)
    id
    FG001
    title
    Part A Dose Level 2 NM21-1480-Q2W 1.5mg
  3. description
    Flat dose level; 8mg (Dose Level 3)
    id
    FG002
    title
    Part A Dose Level 3 NM21-1480-Q2W 8mg
  4. description
    Flat dose level; 24mg (Dose Level 4)
    id
    FG003
    title
    Part A Dose Level 4 NM21-1480-Q2W 24mg
  5. description
    Flat dose level; 80mg (Dose Level 5)
    id
    FG004
    title
    Part A Dose Level 5 NM21-1480-Q2W 80mg
  6. description
    Flat dose level; 240mg (Dose Level 6)
    id
    FG005
    title
    Part A Dose Level 6 NM21-1480-Q2W 240mg
  7. description
    Flat dose level; mg800 (Dose Level 7)
    id
    FG006
    title
    Part A Dose Level 7 NM21-1480-Q2W 800mg
  8. description
    This part of the study consisted of a 1400mg flat dose across one cohort.
    id
    FG007
    title
    Part A2 NM21-1480-Q2W
  9. description
    This part of the study consisted of a 800mg flat dose across three cohorts.
    id
    FG008
    title
    Part B NM21-1480-Q2W
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        2
      5. group Id
        FG004
        num Subjects
        1
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        1
      8. group Id
        FG007
        num Subjects
        1
      9. group Id
        FG008
        num Subjects
        3
      type
      Withdrawal by Subject
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        1
      5. group Id
        FG004
        num Subjects
        2
      6. group Id
        FG005
        num Subjects
        2
      7. group Id
        FG006
        num Subjects
        4
      8. group Id
        FG007
        num Subjects
        1
      9. group Id
        FG008
        num Subjects
        5
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        1
      7. group Id
        FG006
        num Subjects
        4
      8. group Id
        FG007
        num Subjects
        2
      9. group Id
        FG008
        num Subjects
        10
      type
      Study Terminated by Sponsor
    4. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        1
      9. group Id
        FG008
        num Subjects
        2
      type
      Lost to Follow-up
    5. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        3
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      9. group Id
        FG008
        num Subjects
        0
      type
      Progressive Disease
    6. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      9. group Id
        FG008
        num Subjects
        1
      type
      Other
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        6
      6. group Id
        FG005
        num Subjects
        3
      7. group Id
        FG006
        num Subjects
        9
      8. group Id
        FG007
        num Subjects
        5
      9. group Id
        FG008
        num Subjects
        21
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      9. group Id
        FG008
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        6
      6. group Id
        FG005
        num Subjects
        3
      7. group Id
        FG006
        num Subjects
        9
      8. group Id
        FG007
        num Subjects
        5
      9. group Id
        FG008
        num Subjects
        21
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice